Abstract
Two recent studies report changes in human brain responses after exposure topsilocybin, the active ingredient of hallucinogenic mushrooms. Psilocybin increased sensory cortex responses during emotional recollection, but decreased resting-state blood flow in prefrontal cortex, with potential implications for treating depression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have